U.S. Capital Markets Stock News

Cooper Companies (COO) just wrapped up FY 2025 with fourth quarter revenue of $1.1 billion and basic EPS of $0.43, capping a trailing twelve month run of $4.1 billion in revenue and $1.87 in EPS that investors will be dissecting closely. The company has seen revenue move from $3.9 billion and EPS of $1.97 over the twelve months to Q4 2024 to $4.1 billion and EPS of $1.87 over the latest twelve month period, setting a nuanced backdrop for how the current year’s performance fits into its longer...

Rubrik (RBRK) just posted its Q3 2026 scorecard, with quarterly revenue at about $309.9 million and basic EPS of roughly -$0.49, while trailing twelve month revenue sits near $1.1 billion against basic EPS of about -$2.34. The company has seen revenue move from $187.3 million and basic EPS of -$11.48 in early 2025 to $309.9 million and -$0.49 in the latest quarter, and about $679.5 million and -$16.19 on a trailing basis in early 2025 to $1.1 billion and -$2.34 today. This sets up a story of...

If you are wondering whether Everus Construction Group is still a smart place to put fresh money to work, you are not alone. This stock has quickly become one value hunters are watching closely. After climbing an impressive 32.4% year to date and 33.7% over the last year, the share price has cooled slightly in the last month with a 1.6% pullback and is roughly flat over the past week at around $91.75. Recent moves have been driven less by headlines grabbing the front page and more by a...

Argan (AGX) has just posted its Q3 2026 scorecard, with revenue of about $251 million and basic EPS of $2.22, while trailing twelve month EPS sits at $8.76 on revenue of roughly $915 million as the business continues to scale. Over the past year, the company has seen net income climb from $66.11 million to $119.93 million on a trailing basis, and EPS step up from $4.94 to $8.76. This gives investors a cleaner read on how improving margins are feeding through to the bottom line. See our full...

ChargePoint Holdings (CHPT) just posted Q3 2026 results with revenue of about $105.7 million and a basic EPS loss of $2.23, while trailing 12 month figures show revenue of roughly $403.8 million against a basic EPS loss of $10.19. The company has seen quarterly revenue hover in a tight band between about $97.6 million and $108.5 million over the past six quarters, while basic EPS losses have consistently sat in the negative $2.2 to $3.6 range and TTM net income remains deeply in the red...

Imperial Petroleum (IMPP) just moved to raise roughly $60 million through a registered direct offering of composite units, pairing common stock with warrants, a financing decision that can reshape both near term dilution and longer term upside. See our latest analysis for Imperial Petroleum. The financing news lands after a choppy stretch, with a roughly 30% 90 day share price return and about 59% one year total shareholder return suggesting momentum has been rebuilding despite recent...

If you are wondering whether Fidelis Insurance Holdings is a sleeper value play or a stock to avoid, you are in the right place. We are going to unpack what the current price is really telling us about the business. Despite a modest 0.6% gain year to date and a near flat 30 day move of 0.1%, the stock is still down 7.9% over the past year after a recent 5.0% pullback over the last week, which can leave investors unsure whether this is a buying opportunity or a warning sign. Recent news...

If you are wondering whether FLEX LNG still offers good value after its strong run, or if you might be late to the party, this breakdown can help you decide whether it deserves a spot on your radar. The stock is up 28.5% over the last year and 480.2% over five years. Year to date it is still rising 6.4%, despite a flat 0.4% over 30 days and a small 1.7% dip this week that may have caught value hunters’ attention. Recent trading has been driven more by shifting sentiment toward LNG shipping...

Absci Corporation recently dosed the first healthy volunteers in its Phase 1/2a HEADLINE trial of ABS-201, an AI-designed anti-prolactin receptor antibody for androgenetic alopecia, with interim data planned for the second half of 2026. The company also aims to leverage safety and pharmacokinetic insights from this study to accelerate development of ABS-201 for endometriosis, potentially broadening the drug’s addressable patient population. Against this backdrop, we’ll examine how the...

Wondering if Harmonic at around $9.58 is a bargain or a value trap? You are not alone, and this is where a closer look at valuation really starts to matter. The stock has been choppy lately, up just 0.2% over the last week but still down 8.2% over the past month and 26.8% year to date. This hints that sentiment has cooled, even as the long term 5 year return of 36.7% tells a more optimistic story. Recently, investors have been weighing shifting expectations around Harmonic's broadband and...

Walmart (WMT) just posted its Q3 2026 numbers, with revenue of about $179.5 billion and net income of roughly $6.1 billion translating to EPS of $0.77 as investors focus on how these figures feed into the retailer’s earnings momentum story. The company has seen revenue move from around $169.6 billion in Q3 2025 to $179.5 billion in Q3 2026, while trailing twelve month net income climbed from about $19.4 billion to $22.9 billion. This sets the stage for investors to parse how sustained...

Black Diamond Therapeutics recently reported topline Phase 2 data for silevertinib in first-line non-small cell lung cancer patients with non-classical EGFR mutations, and outlined plans to start a randomized Phase 2 trial in newly diagnosed glioblastoma in 2026. The early results, including strong central nervous system response rates and a broad range of EGFR alterations targeted, underscore silevertinib’s potential as a brain-penetrant precision therapy across multiple tumor types. We’ll...

It hasn't been the best quarter for Hess Midstream LP ( NYSE:HESM ) shareholders, since the share price has fallen 16...

Science Applications International (SAIC) opened Q3 2026 with Q2 revenue of about $1.8 billion and basic EPS of $2.72, setting the tone for another data heavy earnings season. The company has seen quarterly revenue move from $1.82 billion in Q2 2025 to $1.77 billion in Q2 2026, while EPS over that same span ranged from $1.59 to $2.72. This frames a period of shifting top line and per share results that investors will be watching closely. With trailing net profit margins now higher than a year...

As the U.S. stock market experiences a modest uptick following key inflation data, major indices like the Dow Jones and S&P 500 are nearing all-time highs, reflecting investor optimism despite recent economic uncertainties. In this environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervalued assets amid fluctuating market conditions.

U.S. stock indexes have recently ticked higher following key inflation data, suggesting cautious optimism among investors as they anticipate upcoming Federal Reserve policy decisions. In the context of this market environment, penny stocks remain a notable area for investors seeking potential growth opportunities outside of traditional blue-chip companies. Though the term "penny stocks" may seem outdated, these smaller or newer companies can still offer significant value and growth potential...

As U.S. stock indexes experience modest gains following key inflation data, investors are closely watching the Federal Reserve's upcoming policy decisions and major corporate moves like Netflix's acquisition of Warner Bros. Discovery. In this dynamic market environment, dividend stocks such as Cal-Maine Foods can offer a reliable income stream and potential stability, making them an attractive option for those looking to enhance their portfolios amidst economic fluctuations.

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

This article explores whether MNTN is a beaten-down bargain or a value trap at current levels, and what the market might be overlooking. After sliding 48.8% year to date and another 9.2% over the last month, the stock has only managed a modest 0.7% uptick in the past week. This mix hints at both lingering caution and potential rebound interest. Recent headlines have focused on MNTN’s positioning in the evolving media and ad tech landscape, including its push to differentiate in a crowded...

C3.ai (AI) just posted its Q2 2026 numbers, with revenue at about $75.1 million and basic EPS at roughly -$0.75, as the company continues to run at a loss. Looking back over recent quarters, revenue has moved from about $94.3 million in Q2 2025 to $75.1 million in Q2 2026. Over the same period, basic EPS shifted from around -$0.52 to -$0.75, and trailing 12 month EPS now sits near -$2.84 alongside revenue of roughly $352.9 million. This sets the stage for a results season where investors are...

When we invest, we're generally looking for stocks that outperform the market average. And in our experience, buying...

With a price-to-earnings (or "P/E") ratio of 42x Zurn Elkay Water Solutions Corporation ( NYSE:ZWS ) may be sending...

Wondering if Eastman Chemical is a beaten down value play or a value trap at current levels? You are not alone. This article aims to unpack exactly that. With the share price around $60.66 and down 31.5% year to date and 37.8% over the past year, the market has clearly reset its expectations and is forcing investors to rethink the risk reward profile. Recent headlines have focused on Eastman’s strategic push into specialty materials and circular recycling initiatives, alongside ongoing...

Methode Electronics (MEI) just posted Q2 2026 results with revenue of $246.9 million and a basic EPS loss of $0.28, as the trailing twelve months show revenue of $984.4 million alongside a basic EPS loss of $1.78. The company has seen quarterly revenue move in a relatively tight band from $292.6 million in Q2 2025 to $246.9 million in Q2 2026, while EPS has stayed in negative territory across the same stretch. This is setting the stage for investors to focus on how long current margin...